Skip to main content

RBCK1 Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-27105

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-27105
NBP2-27105SS

Key Product Details

Species Reactivity

Validated:

Human, Mouse, Primate

Predicted:

Rhesus Macaque (99%). Backed by our 100% Guarantee.

Applications

Immunocytochemistry/ Immunofluorescence, Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit IgG

Concentration

1.0 mg/ml

Product Specifications

Immunogen

A portion of amino acids 150-200 from human RBCk1 was used as the immunogen for this antibody.

Reactivity Notes

Orangutan, Chimpanzee (100%), New world monkey (89%), Bovine, Guinea Pig, Mole Rat (83%), Canine, Elephant, Rabbit (78%), Panda, Oppossum (67%), Rat (61%).

Clonality

Polyclonal

Host

Rabbit

Isotype

IgG

Scientific Data Images for RBCK1 Antibody

Western Blot: RBCK1 Antibody [NBP2-27105]

Western Blot: RBCK1 Antibody [NBP2-27105]

Western Blot: RBCK1 Antibody [NBP2-27105] - Analysis of RBCK1 using RBCK1 antibody. A549 cell lysate in the 1) pre immune sera and 2) abesence of immunizing peptide and 3) 3T3 cell lysate probed with 2 ug/ml of RBCK1 antibody. Goat anti-rabbit Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.
Immunocytochemistry/ Immunofluorescence: RBCK1 Antibody [NBP2-27105]

Immunocytochemistry/ Immunofluorescence: RBCK1 Antibody [NBP2-27105]

Immunocytochemistry/Immunofluorescence: RBCK1 Antibody [NBP2-27105] - SK-MEL-28 cells were fixed for 10 minutes using 10% formalin and then permeabilized for 5 minutes using 1X PBS + 0.05% Triton-X100. The cells were incubated with anti-RBCK1 at 10 ug/ml overnight at 4C and detected with an anti-rabbit Dylight 488 (Green) at a 1:500 dilution. Nuclei were counterstained with DAPI (Blue). Cells were imaged using a 40X objective.

Applications for RBCK1 Antibody

Application
Recommended Usage

Immunocytochemistry/ Immunofluorescence

5-10 ug/ml

Western Blot

2-4ug/ml

Formulation, Preparation, and Storage

Purification

Protein A purified

Formulation

PBS

Preservative

0.05% Sodium Azide

Concentration

1.0 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: RBCK1

RBCk1, also known as HOIL-1L, acts as an E3 ubiquitin-protein ligase, or as part of an E3 complex that contains a zf-RanBP (Zn-finger in Ran binding protein) and a zf-C3HC4 (RING finger) domain. RBCk1 catalyzes the ubiquitination and degradation of IRF3. Both RBCk1 and IRF3 are activated by viral infections and IRF3 is a prerequisite trigger for induction of type I Interferons (1). RBCk1 also negatively regulates TNF and IL1 induced NF-fUB activation (2). Thus it appears RBCk1 and IRF3 interaction represents a controlling antiviral regulatory channel but also that RBCk1 and ubiquitination pathways (3, 4) also are related to NF-kB and its role as an anti-viral response pathway.

Alternate Names

C20orf18, EC 6.3.2.-, HBV associated factor 4, HBV-associated factor 4, Heme-oxidized IRP2 ubiquitin ligase 1, Hepatitis B virus X-associated protein 4, HOIL-1, RanBP-type and C3HC4-type zinc finger containing 1, ranBP-type and C3HC4-type zinc finger-containing protein 1, RBCC protein interacting with PKC1, RBCK2, RNF54RING finger protein 54, UBCE7IP3HOIL1, ubiquitin conjugating enzyme 7 interacting protein 3, Ubiquitin-conjugating enzyme 7-interacting protein 3, XAP3, XAP4chromosome 20 open reading frame 18, ZRANB4

Gene Symbol

RBCK1

UniProt

Additional RBCK1 Products

Product Documents for RBCK1 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for RBCK1 Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...